RxDoctor Payments Data

Magan Parker

Nurse Practitioner · Dothan, ALNPI 1932692282

Payments from drug & device makers

$2,988in general payments, 2019–2025

Across 181 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$411
  • E.r. Squibb & Sons, L.L.C.$223
  • Abbott$210
  • Merck$200
  • Pfizer$176
  • Lilly USA, LLC$167
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$2,988100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,988 in reported general payments places this provider in the 85th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban113$80,319
MultaqDronedarone Hcl13$10,057
Ranolazine ErRanolazine52$3,776
Propafenone Hcl36$1,530
Midodrine Hcl31$1,215
Nebivolol Hcl36$1,195
Diltiazem 24hr Er (Cd)Diltiazem Hcl23$1,168
Mexiletine Hcl12$1,124
Olmesartan Medoxomil96$1,099
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide28$876
Propranolol Hcl30$731
Metoprolol Succinate42$638
Flecainide Acetate19$551
Carvedilol54$465
Nitroglycerin37$326

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$176$80,319113 claims
Sanofi-aventis U.S. LLCMultaq$16$10,05713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,505 nurse practitioner providers in Alabama.

Other nurse practitioner in Dothan

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →